BEIJING (Reuters) – China National Pharmaceutical Group (Sinopharm) has the capacity to provide more than 1 billion COVID-19 vaccine doses to the rest of the world in the second half of this year, the firm’s chairman said late on Wednesday.
That level of supply capability assumes vaccination demand in China is being met, Liu said at a panel of the Global Health Forum of the Boao Forum for Asia.
(Reporting by Roxanne Liu and Ryan Woo; Editing by Peter Graff)
